| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| BUY | NEUTRAL | SELL | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 4.18▲ | 4.19▲ | 4.19▲ | 4.36▼ | 4.90▼ |
| MA10 | 4.18▲ | 4.15▲ | 4.15▲ | 4.48▼ | 6.30▼ |
| MA20 | 4.13▲ | 4.12▲ | 4.23▼ | 4.98▼ | 8.53▼ |
| MA50 | 4.10▲ | 4.38▼ | 4.52▼ | 6.73▼ | 7.24▼ |
| MA100 | 4.19▲ | 4.85▼ | 4.97▼ | 8.69▼ | 7.68▼ |
| MA200 | 4.67▼ | 5.49▼ | 6.85▼ | 7.52▼ | 14.57▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.005▲ | 0.035▲ | 0.028▲ | 0.066▲ | -0.745▼ |
| RSI | 56.612▲ | 47.340▼ | 44.095▼ | 34.425▼ | 41.985▼ |
| STOCH | 62.281 | 73.282 | 73.282 | 22.414 | 7.649▼ |
| WILL %R | -36.364 | -35.556 | -29.630 | -90.452▼ | -99.043▼ |
| CCI | 55.765 | 58.421 | 64.018 | -109.515▼ | -84.013 |
| ▲ GAP | $ARTL Open Gap Up %2 | Set Alert |
|
Wednesday, October 15, 2025 06:36 AM
ART26.12 Phase 1 Data Demonstrated No Safety Concerns, Predictable Linear Plasma Exposure, and Options for Dosing in Either Fed or Fasted Conditions ART27.13 Interim Phase 2 Data Showed Substantial ...
|
|
Wednesday, October 01, 2025 01:17 PM
Artelo Biosciences, Inc. (Nasdaq: ARTL), a clinical-stage pharmaceutical company focused on modulating lipid-signaling pathways to develop treatments for people living with cancer, pain, dermatologic, ...
|
|
Wednesday, October 01, 2025 01:17 PM
Artelo Biosciences, Inc. (Nasdaq: ARTL), a clinical-stage pharmaceutical company focused on modulating lipid-signaling pathways to develop treatments for people living with cancer, pain, dermatologic, ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 15/10/25 | 4.23 | 4.27 | 4.15 | 4.19 | 31,069 |
| 14/10/25 | 4.10 | 4.22 | 4.045 | 4.14 | 112,747 |
| 13/10/25 | 4.51 | 4.8273 | 4.00 | 4.13 | 165,230 |
| 10/10/25 | 4.85 | 4.87 | 4.40 | 4.51 | 57,925 |
| 09/10/25 | 4.75 | 4.97 | 4.63 | 4.85 | 81,588 |
| 08/10/25 | 4.38 | 4.73 | 4.38 | 4.66 | 35,425 |
| 07/10/25 | 4.56 | 4.78 | 4.35 | 4.36 | 70,787 |
| 06/10/25 | 4.65 | 4.70 | 4.29 | 4.49 | 60,093 |
| 03/10/25 | 4.85 | 4.85 | 4.657 | 4.69 | 35,854 |
| 02/10/25 | 4.76 | 4.925 | 4.69 | 4.82 | 37,957 |
|
|
||||
|
|
||||
|
|